Utah Medical Products
UTMD
63 hedge funds and large institutions have $147M invested in Utah Medical Products in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
3% more funds holding
Funds holding: 61 → 63 (+2)
1% more capital invested
Capital invested by funds: $146M → $147M (+$1.71M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$1.47M |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$752K |
| 3 |
CYG
Clean Yield Group
Norwich,
Vermont
|
+$520K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$464K |
| 5 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$537K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$297K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$280K |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$109K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$76.2K |
UTMD Hedge Fund Activity: Q2 2015 in Review
63 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2015, worth a combined $147M — up 1.2% from $146M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new UTMD positions and 2 closed out — a net gain of 2 holders — while 30 added to existing stakes and 17 trimmed.
The largest buyer was Ancora Advisors, opening a new position worth an estimated $1.47M. The largest seller was Morgan Dempsey Capital Management, cutting an estimated $537K.
- 63 institutional investors held Utah Medical Products (UTMD) as of Q2 2015, up from 61 in Q1 2015.
- Funds reported $147M of Utah Medical Products stock for Q2 2015, up 1.2% quarter-over-quarter.
- 4 funds opened new Utah Medical Products positions in Q2 2015 and 2 closed out, a net change of +2 holders.
- The largest Utah Medical Products buyer in Q2 2015 was Ancora Advisors, an estimated $1.47M added.
- The largest Utah Medical Products seller in Q2 2015 was Morgan Dempsey Capital Management, an estimated $537K sold.
Based on aggregated 13F filings for Q2 2015.